Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLeonaBio, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

LeonaBio, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • No presentations available at this time
    Jan 8, 2026LeonaBio
  • No presentations available at this time
    Jan 8, 2026LeonaBio
  • ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective in co-culture of human iPSC-derived motor neurons and muscle
    Nov 13, 2025LeonaBio
  • Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease; Efficacy and Safety from the LIFT-AD Trial
    Nov 13, 2025LeonaBio
  • Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients with ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study
    Apr 1, 2025LeonaBio
  • ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer
    Nov 1, 2024LeonaBio
  • Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination
    Mar 1, 2024LeonaBio
  • Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial
    Dec 7, 2023LeonaBio
  • Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2
    Dec 7, 2023LeonaBio
  • ATH-1020, a novel small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective and improves motor function in preclinical models of Parkinson’s disease
    Dec 13, 2021LeonaBio
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions